SDK BioTechnologies is developing enabling, high value added solutions for pre-clinical research and clinical diagnostics through the integration of innovative design, advanced materials and outstanding engineering. The main product is a new platform for multiplex binding assays that solves the reagents cross-reactivity issue. SDK’s technology will shorten the development time, improve the efficiency and lower the price per data point of present and future medical tests.



ChatbotIcon Chat with us!
Powered by ICE2017